TickerFacts.

Allurion Technologies, Inc. (ALUR): Revenue

Annual figures by period end, from SEC filings.

$15.23M
Year ended 2025-12-31
$12.60M
Trailing 12 months to 2026-03-31
-38.1%
3-year compound annual growth
$64.21M2022-12-31: $64.21M2023-12-31: $53.47M2024-12-31: $32.11M2025-12-31: $15.23M$15.23M
2022-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$15.23M-52.6%2026-03-30, From 2025-01-01
2024-12-31$32.11M-39.9%2026-03-30, From 2024-01-01
2023-12-31$53.47M-16.7%2025-08-28, From 2023-01-01
2022-12-31$64.21Mn/a2025-08-28, From 2022-01-01

Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Allurion Technologies, Inc. (ALUR)2025-12-31$15.23M-52.6%
Biotricity Inc. (BTCY)2026-03-31$16.00M+16.0%
Profound Medical Corp. (PROF)2025-12-31$16.10M+50.7%
Vivos Therapeutics, Inc. (VVOS)2025-12-31$17.44M+16.0%
Nephros Inc (NEPH)2025-12-31$18.79M+32.7%
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31$19.53M+36.7%
Spectral AI, Inc. (MDAI)2025-12-31$19.65M-33.6%
Nexgel, Inc. (NXGL)2025-12-31$11.42M+31.5%
DarioHealth Corp. (DRIO)2025-12-31$22.36M-17.3%

Compare ALUR, BTCY, PROF, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗